Citations

Showing 10 of 107868 citations.

Comparative Performance of Two Polyp Detection Systems on CT Colonography
Booya, Fargol, Summers, Ronald M. , Guendel, Lutz, Schmidt, Bernhard , Fidler, Jeff L. , Fletcher, Joel G. , Roy, David P. , McCollough, Cynthia H. , Fidler, Jeff L.

Mayo Clinic

American Journal of Roentgenology | July 23, 2007 | Volume: 189 | Issue: 2 | Pages: 277-282

10.2214/ajr.07.2289 | PMID 17646451 Get It

Successful Preventive Therapy in Hypnic Headache Using Hypnotics: A Case Report
Garza, Ivan , Swanson, Jerry W.

Mayo Clinic

Cephalalgia | July 23, 2007 | Volume: 27 | Issue: 9 | Pages: 1080-1081

10.1111/j.1468-2982.2007.01364.x | PMID 17645753 Get It

Reduction of the false‐positive rate in newborn screening by implementation of MS/MS‐based second‐tier tests: The Mayo Clinic experience (2004–2007)
Matern, Dietrich , Tortorelli, Silvia , Oglesbee, Devin , Gavrilov, Dimitar , Rinaldo, Piero, Oglesbee, Devin

Mayo Clinic

Journal of Inherited Metabolic Disease | July 20, 2007 | Volume: 30 | Issue: 4 | Pages: 585-592

10.1007/s10545-007-0691-y | PMID 17643193 Get It

SummaryThe continued expansion of newborn screening programmes to include additional conditions increases the responsibility of newborn screening laboratories to provide testing with the highest sensitivity and specificity to allow for identification of affected patients while minimizing the false‐positive rate. Some assays and analytes are particularly problematic. Over recent years, our laboratory tried to improve this situation by developing second‐tier tests to reduce false‐positive results in the screening for congenital adrenal hyperplasia (CAH), tyrosinaemia type I, methylmalonic acidaemias, homocystinuria, and maple syrup urine disease (MSUD). Beginning in 2004, this approach was applied to Mayo's newborn screening programme and resulted in a false‐positive rate of 0.09%, a positive predictive value of 41%, and a positive detection rate of 1 affected case in 1672 babies screened.
Thrombolytic Therapy for Acute Ischemic Stroke
Demaerschalk, Bart M.

Mayo Clinic

Stroke | July 20, 2007 | Volume: 38 | Issue: 8 | Pages: 2215-2216

10.1161/strokeaha.107.494112 | PMID 17641237 Get It

Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, Version 1.5, on Clinical Laboratory Operations
Germer, Jeffrey J., Bendel, Jordan L., Dolenc, Craig A., Nelson, Sarah R., Masters, Amanda , Gerads, Tara M., Mandrekar, Jayawant N. , Mitchell, P. Shawn, Yao, Joseph D.

Mayo Clinic

Journal of Clinical Microbiology | July 19, 2007 | Volume: 45 | Issue: 9 | Pages: 3101-3104

10.1128/jcm.00656-07 | PMID 17634308 Get It

ABSTRACT The COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5 (CAP/CA), and the COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, were compared. CAP/CA reduced and consolidated labor while modestly increasing assay throughput without increased failure rates or direct costs, regardless of batch size and assay format.
A Unique Element in the Cytoplasmic Tail of the Type II Transforming Growth Factor-β Receptor Controls Basolateral Delivery
Shapira, Keren E. , Henis, Yoav I. , Leof, Edward B. , Murphy, Stephen J.

Mayo Clinic

Molecular Biology of the Cell | July 19, 2007 | Volume: 18 | Issue: 10 | Pages: 3788-3799

10.1091/mbc.e06-10-0930 | PMID 17634290 Get It

Transforming growth factor (TGF)-β receptors stimulate diverse signaling processes that control a wide range of biological responses. In polarized epithelia, the TGFβ type II receptor (T2R) is localized at the basolateral membranes. Sequential cytoplasmic truncations resulted in receptor missorting to apical surfaces, and they indicated an essential targeting element(s) near the receptor's C terminus. Point mutations in the full-length receptor confirmed this prediction, and a unique basolateral-targeting region was elucidated between residues 529 and 538 (LTAxxVAxxR) that was distinct, but colocalized within a clinically significant signaling domain essential for TGFβ-dependent activation of the Smad2/3 cascade. Transfer of a terminal 84 amino-acid fragment, containing the LTAxxVAxxR element, to the apically sorted influenza hemagglutinin (HA) protein was dominant and directed basolateral HA expression. Although delivery to the basolateral surfaces was direct and independent of any detectable transient apical localization, fluorescence recovery after photobleaching demonstrated similar mobility for the wild-type receptor and a missorted mutant lacking the targeting motif. This latter finding excludes the possibility that the domain acts as a cell membrane retention signal, and it supports the hypothesis that T2R sorting occurs from an intracellular compartment.
A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus Challenge
Valle, Jorge Reyes del, Devaux, Patricia , Hodge, Gregory, Wegner, Nicholas, McChesney, Michael B., Cattaneo, Roberto , Valle, Jorge Reyes‐del

Mayo Clinic

Journal of Virology | July 19, 2007 | Volume: 81 | Issue: 19 | Pages: 10597-10605

10.1128/jvi.00923-07 | PMID 17634218 Get It

ABSTRACT Hepatitis B virus (HBV) acute and chronic infections remain a major worldwide health problem. Towards developing an anti-HBV vaccine with single-dose scheme potential, we engineered infectious measles virus (MV) genomic cDNAs with a vaccine strain background and expression vector properties. Hepatitis B surface antigen (HBsAg) expression cassettes were inserted into this cDNA and three MVs expressing HBsAg at different levels generated. All vectored MVs, which secrete HBsAg as subviral particles, elicited humoral responses in MV-susceptible genetically modified mice. However, small differences in HBsAg expression elicited vastly different HBsAg antibody levels. The two vectors inducing the highest HBsAg antibody levels were inoculated into rhesus monkeys ( Macaca mulatta ). After challenge with a pathogenic MV strain (Davis 87 ), control naive monkeys showed a classic measles rash and high viral loads. In contrast, all monkeys immunized with vaccine or a control nonvectored recombinant vaccine or HBsAg-expressing vectored MV remained healthy, with low or undetectable viral loads. After a single vaccine dose, only the vector expressing HBsAg at the highest levels elicited protective levels of HBsAg antibodies in two of four animals. These observations reveal an expression threshold for efficient induction of HBsAg humoral immune responses. This threshold is lower in mice than in macaques. Implications for the development of divalent vaccines based on live attenuated viruses are discussed.
Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53)
Schild, Steven E. , Bonner, James A. , Hillman, Shauna L., Kozelsky, Timothy F., Vigliotti, Antonio P., Marks, Randolph S., Graham, David L. , Soori, Gamini S. , Kugler, John W., Tenglin, Richard C., Wender, Donald B., Adjei, Alex A. , Schild, Steven

Mayo Clinic

Journal of Clinical Oncology | July 18, 2007 | Volume: 25 | Issue: 21 | Pages: 3124-3129

10.1200/jco.2006.09.9606 | PMID 17634491 Get It

Purpose To evaluate the outcome of patients with limited-stage small-cell lung cancer (L-SCLC) treated with cisplatin and etoposide (PE), early prophylactic cranial irradiation (PCI), and high-dose twice-daily thoracic radiotherapy (bid RT). Patients and Methods A total of 76 assessable patients were treated on this phase II trial, which included six cycles of PE. PCI (25 Gy/10 fractions) was delivered during cycle 3 to responding patients. Cycles 4 and 5 included concurrent chemotherapy and thoracic RT (30 Gy/20 bid fractions, a 2-week break, and another 30 Gy/20 bid fractions). Results Of the 76 assessable patients, 74 patients (97%) suffered grade 3 or greater (3+) toxicity and 61 patients (80%) had grade 4 or greater (4+) toxicity. Of these adverse events, grade 3+ hematologic toxicity occurred in 72 patients (95%), and grade 3+ nonhematologic toxicity occurred in 55 patients (72%). Only one (2%) of the 61 patients who received PCI experienced treatment failure in the brain. The 5-year survival rate of the 76 assessable patients was 24% (median, 20 months). The 5-year survival rate of the 64 patients who received thoracic RT was 29% (median, 22 months). The 5-year cumulative incidence of in-field treatment failure was 34%. Conclusion This regimen included a high total dose of bid TRT, which resulted in a favorable 5-year survival rate. Local failure remains a problem that will require additional investigation. Newer technology should allow the safe administration of greater doses of RT, which should improve patient outcome. Data from eight trials were combined to demonstrate a relationship between RT dose fractionation and 5-year survival.
CSF Rhinorrhea: 95 Consecutive Surgical Cases with Long Term Follow-Up at the Mayo Clinic
Gassner, Holger G., Ponikau, Jens U., Sherris, David A., Kern, Eugene B.

Mayo Clinic

American Journal of Rhinology | July 18, 2007 | Volume: 13 | Issue: 6 | Pages: 439-448

10.2500/105065899781329610 | PMID 10631399 Get It

A persistent cerebrospinal fluid (CSF) leak is potentially lethal, and surgical treatment is often required. CSF leak repair is an infrequently performed procedure, and only limited information is available on the long term success of the surgical techniques that are used. This retrospective chart review includes 95 patients who underwent various types of repair surgery for CSF rhinorrhea at the Mayo Clinic. The purpose of this study was to extract factors such as the choice of sealing material, etiology, location of defect(s), surgical approach, and previous procedures, and to analyze their association with the long term success and failure of surgical repair. The mean time interval in this study between unsuccessful surgery and recurrence was 50.8 months, and the mean follow-up 109 months. Among the various approaches, defects repaired endonasally had the lowest recurrence rate. Local nasal mucosa advancement flaps failed more frequently (83.3% failure) than other types of graft material (p = 0.023). These failures took place in a delayed fashion (mean interval until failure: 80 months). Local osteo-mucoperiosteal or chondro-mucoperichondrial flaps (22.2% recurrence rate) and free graft material (15.6% recurrence rate) had the best outcome. The use of fibrin glue to fixate free grafts did not improve the result in this series. Transcranial procedures were associated with a higher complication rate than extracranial procedures (12.9% versus 3.2%). Overall, successful repair was achieved in 91.6% of the patients. We discourage the use of mucosa advancement flaps and advocate free grafts or pedicled osteomucoperiosteal or chondro-mucoperichondrial flaps as sealing material of choice in the majority of cases. The occurrence of delayed failure has to be considered when evaluating reports of CSF rhinorrhea after surgical repair.
THE RELIABILITY OF INTRADISCAL STRESS PROFILOMETRY IN CADAVERIC LUMBAR DISCS
Gay, Ralph E. , Ilharreborde, Brice , Bridges, Jonathan, An, Kai‐Nan , Zhao, Kristin D.

Mayo Clinic

Journal of Musculoskeletal Research | July 18, 2007 | Volume: 10 | Issue: 04 | Pages: 163-171

10.1142/s0218957706001844 Get It

The measurement of intradiscal stress has been primarily limited to nucleus pulposus pressure. Intradiscal stress profilometry is a technique that measures stress in both the nucleus pulposus (hydrostatic) and annulus fibrosus (compression). Evidence from animal studies suggests that distraction may affect disc physiology and promote repair. A study was performed to determine the reliability of intradiscal stress profilometry measurements in the anterior, posterior, and nucleus regions of cadaveric lumbar discs. Four fresh-frozen human lumbar motion segments were prepared and tested. Five profiles were obtained during two conditions of compression and three conditions of distraction. Discs were then graded for degenerative change. Reliability was judged by within-specimen coefficients of variation. The coefficients of variation were smaller (more reliable) for compression conditions than for distraction conditions. Within-specimen coefficients during compression ranged from 1.58% to 37.2% in the nucleus, 3.9% to 67.4% in the anterior annulus, and 2.3% to 25.5% in the posterior annulus. The reliability of intradiscal stress profilometry is acceptable for repeated measures studies evaluating within-specimen changes, but the sample size will vary depending on the test conditions used and the disc region of interest.